FdaApplication
NDA 202192
Identifiers
- fda_app_no: NDA202192
Properties
| Property | Value |
|---|---|
| applicant_name | INCYTE CORP |
| application_type | NDA |
| approval_date | 2011-11-16 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| JAKAFI | RUXOLITINIB PHOSPHATE | EQ 25MG BASE | TABLET;ORAL |
| JAKAFI | RUXOLITINIB PHOSPHATE | EQ 5MG BASE | TABLET;ORAL |
| JAKAFI | RUXOLITINIB PHOSPHATE | EQ 20MG BASE | TABLET;ORAL |
| JAKAFI | RUXOLITINIB PHOSPHATE | EQ 15MG BASE | TABLET;ORAL |
| JAKAFI | RUXOLITINIB PHOSPHATE | EQ 10MG BASE | TABLET;ORAL |
5 products